Family Medicine · New Roads, LA
NPI
1811997141
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
310 Durel Dr
New Roads, LA, 70760
Phone (225) 713-2400
Groups this clinician bills Medicare through
Medicare paid, 2023
$47.27
14 services
Medicare patients, 2023
13
Average age 78
Drug cost, 2024
$1.7M
15,536 prescriptions
Company payments, 2025
$2,168
From 25 companies
Medicare prescription drug claims, 2024
In 2024, the drug Paul B Rachal prescribed most often to Medicare patients was Amlodipine Besylate, with 736 prescriptions and refills. In total Paul B Rachal wrote 15,536 Medicare prescriptions that cost $1.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Amlodipine Besylate Generic | 736 | 1,659 | 178 | $2,859 |
| Pantoprazole Sodium Generic | 657 | 1,268 | 155 | $5,416 |
| Levothyroxine Sodium Generic | 443 | 975 | 91 | $2,630 |
| Montelukast Sodium Generic | 427 | 858 | 107 | $3,195 |
| Atorvastatin Calcium Generic | 410 | 970 | 100 | $4,517 |
| Rosuvastatin Calcium Generic | 380 | 1,039 | 120 | $3,621 |
| Doxycycline Monohydrate Generic | 363 | 369 | 183 | $4,812 |
| Alendronate Sodium Generic | 317 | 522 | 85 | $1,524 |
| Pravastatin Sodium Generic | 315 | 827 | 84 | $3,592 |
| Meloxicam Generic | 284 | 530 | 80 | $1,088 |
| Dexamethasone Generic | 261 | 261 | 167 | $1,690 |
| Trazodone Hcl Generic | 258 | 402 | 51 | $1,454 |
| Ozempic Semaglutide | 252 | 353 | 55 | $314K |
| Gabapentin Generic | 244 | 338 | 54 | $2,473 |
| Metformin Hcl Generic | 243 | 616 | 75 | $1,078 |
Brand drugs: 1,952 claims; generic drugs: 13,470 claims; opioid claims: 194.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul B Rachal $2,168 ($2,168 in general payments such as food, travel and fees) from 25 companies. The largest payer was Abbott Laboratories with $281.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 6 | $281 |
| Novo Nordisk Inc NVO | 11 | $280 |
| Abbvie Inc. ABBV | 27 | $272 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $219 |
| Lilly USA, LLC LLY | 12 | $208 |
| Collegium Pharmaceutical, Inc. COLL | 4 | $147 |
| Pfizer Inc. PFE | 6 | $121 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $90.51 |
| GlaxoSmithKline, LLC. GSK | 5 | $88.44 |
| Vanda Pharmaceuticals Inc. VNDA | 3 | $83.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.